Pharming Group N.V. Cost Of Sales
Pharming Group N.V. (PHAR) reported Cost Of Sales of $45.50 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-02.
Financial Statements › Expense Statement
ifrs-full:CostOfSales · last filed 2026-04-02
EUR
| Period end | Cost Of Sales 12 month |
|---|---|
| 2020-12-31 | 20.60M EUR 20-F · filed 2021-04-07 |
| 2019-12-31 | 21.36M EUR 20-F · filed 2021-04-07 |
| 2018-12-31 | 22.18M EUR 20-F · filed 2021-04-07 |
USD
| Period end | Cost Of Sales 12 month |
|---|---|
| 2025-12-31 | $45.50M 20-F · filed 2026-04-02 |
| 2024-12-31 | $35.40M 20-F · filed 2026-04-02 |
| 2023-12-31 | $25.21M 20-F · filed 2026-04-02 |
| 2022-12-31 | $17.56M 20-F · filed 2025-04-03 |
| 2021-12-31 | $21.14M 20-F · filed 2024-04-04 |
| 2020-12-31 | $23.54M 20-F · filed 2023-04-05 |
| 2019-12-31 | $23.93M 20-F · filed 2022-04-06 |